François‐Xavier Gros

机构：Université de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Bordeaux Population Health, Neurocentre Magendie · ORCID：0000-0001-8998-3039

发表论文 60 篇 · 总被引 838 次 · h-index 12

代表论文

• Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study (2025 · Nature Cancer · 被引 35)
• Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry (2025 · Blood Advances · 被引 5)
• TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas (2025 · Blood Advances · 被引 4)
• Axi-cel delivers similar outcomes regardless of ASCT-eligibility in second line R/R LBCL: Combined data from ZUMA-7 and ALYCANTE (2025 · Blood · 被引 2)
• Large B-cell lymphoma: The LYSA pragmatic guidelines (2025 · European Journal of Cancer · 被引 1)
• Outcomes and treatment patterns of patients with primary mediastinal b-cell lymphoma after CAR-t cell therapy failure : A descar-t analysis (2025 · Blood · 被引 1)